nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Alfentanil—ALB—ulcerative colitis	0.00455	0.363	CrCbGaD
Remifentanil—Alfentanil—ABCB1—ulcerative colitis	0.00434	0.347	CrCbGaD
Remifentanil—Pethidine—ALB—ulcerative colitis	0.00205	0.164	CrCbGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00164	0.00918	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00161	0.00903	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—RIPK2—ulcerative colitis	0.00159	0.00894	CbGpPWpGaD
Remifentanil—Fentanyl—ABCB1—ulcerative colitis	0.00159	0.127	CrCbGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00155	0.0087	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00155	0.00869	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.00155	0.00868	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00154	0.00863	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00143	0.00806	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00143	0.00805	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.0014	0.00787	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00138	0.00775	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00136	0.00763	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00136	0.00762	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00135	0.00757	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.00131	0.00734	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.0013	0.00728	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00128	0.00719	CbGpPWpGaD
Remifentanil—OPRM1—Opioid Signalling—ADCY5—ulcerative colitis	0.00128	0.00717	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00124	0.00696	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00123	0.00691	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00123	0.0069	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00121	0.00681	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00121	0.0068	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00121	0.00679	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.0012	0.00676	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00115	0.00644	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00114	0.0064	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00114	0.00639	CbGpPWpGaD
Remifentanil—Body temperature increased—Azathioprine—ulcerative colitis	0.00112	0.00139	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00112	0.0063	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00112	0.00138	CcSEcCtD
Remifentanil—Haemoglobin—Dexamethasone—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Remifentanil—Haemoglobin—Betamethasone—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Remifentanil—Constipation—Mesalazine—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Remifentanil—Pain—Mesalazine—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Remifentanil—Haemorrhage—Betamethasone—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Remifentanil—Haemorrhage—Dexamethasone—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Remifentanil—Angiopathy—Methylprednisolone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Remifentanil—Hallucination—Betamethasone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Remifentanil—Hallucination—Dexamethasone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Remifentanil—Immune system disorder—Methylprednisolone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Remifentanil—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.0011	0.00616	CbGpPWpGaD
Remifentanil—Arrhythmia—Triamcinolone—ulcerative colitis	0.00109	0.00135	CcSEcCtD
Remifentanil—Diarrhoea—Budesonide—ulcerative colitis	0.00109	0.00135	CcSEcCtD
Remifentanil—Arrhythmia—Methylprednisolone—ulcerative colitis	0.00109	0.00134	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00109	0.0061	CbGpPWpGaD
Remifentanil—Hyperglycaemia—Prednisone—ulcerative colitis	0.00109	0.00134	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00108	0.00606	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00107	0.00599	CbGpPWpGaD
Remifentanil—Visual impairment—Dexamethasone—ulcerative colitis	0.00107	0.00132	CcSEcCtD
Remifentanil—Visual impairment—Betamethasone—ulcerative colitis	0.00107	0.00132	CcSEcCtD
Remifentanil—Feeling abnormal—Mesalazine—ulcerative colitis	0.00107	0.00132	CcSEcCtD
Remifentanil—Erythema—Triamcinolone—ulcerative colitis	0.00106	0.00131	CcSEcCtD
Remifentanil—Erythema—Methylprednisolone—ulcerative colitis	0.00106	0.00131	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00106	0.00595	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00106	0.00593	CbGpPWpGaD
Remifentanil—Dizziness—Budesonide—ulcerative colitis	0.00105	0.0013	CcSEcCtD
Remifentanil—Hypersensitivity—Azathioprine—ulcerative colitis	0.00105	0.00129	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00104	0.00583	CbGpPWpGaD
Remifentanil—Syncope—Prednisolone—ulcerative colitis	0.00104	0.00128	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00103	0.00579	CbGpPWpGaD
Remifentanil—Urticaria—Mesalazine—ulcerative colitis	0.00103	0.00127	CcSEcCtD
Remifentanil—Body temperature increased—Mesalazine—ulcerative colitis	0.00102	0.00126	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00102	0.00574	CbGpPWpGaD
Remifentanil—Loss of consciousness—Prednisolone—ulcerative colitis	0.00102	0.00125	CcSEcCtD
Remifentanil—Vomiting—Budesonide—ulcerative colitis	0.00101	0.00125	CcSEcCtD
Remifentanil—Syncope—Hydrocortisone—ulcerative colitis	0.00101	0.00125	CcSEcCtD
Remifentanil—Angiopathy—Dexamethasone—ulcerative colitis	0.001	0.00124	CcSEcCtD
Remifentanil—Angiopathy—Betamethasone—ulcerative colitis	0.001	0.00124	CcSEcCtD
Remifentanil—Rash—Budesonide—ulcerative colitis	0.001	0.00124	CcSEcCtD
Remifentanil—Dermatitis—Budesonide—ulcerative colitis	0.001	0.00124	CcSEcCtD
Remifentanil—Convulsion—Prednisolone—ulcerative colitis	0.001	0.00124	CcSEcCtD
Remifentanil—Headache—Budesonide—ulcerative colitis	0.000997	0.00123	CcSEcCtD
Remifentanil—Hypertension—Prednisolone—ulcerative colitis	0.000997	0.00123	CcSEcCtD
Remifentanil—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000991	0.00123	CcSEcCtD
Remifentanil—Arrhythmia—Dexamethasone—ulcerative colitis	0.000989	0.00122	CcSEcCtD
Remifentanil—Arrhythmia—Betamethasone—ulcerative colitis	0.000989	0.00122	CcSEcCtD
Remifentanil—OPRM1—IL4-mediated signaling events—JAK2—ulcerative colitis	0.000986	0.00553	CbGpPWpGaD
Remifentanil—Bradycardia—Prednisone—ulcerative colitis	0.000982	0.00121	CcSEcCtD
Remifentanil—Convulsion—Hydrocortisone—ulcerative colitis	0.000977	0.00121	CcSEcCtD
Remifentanil—Hypertension—Hydrocortisone—ulcerative colitis	0.000974	0.0012	CcSEcCtD
Remifentanil—Diarrhoea—Azathioprine—ulcerative colitis	0.000973	0.0012	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—ulcerative colitis	0.000969	0.0012	CcSEcCtD
Remifentanil—Haemorrhage—Prednisone—ulcerative colitis	0.000964	0.00119	CcSEcCtD
Remifentanil—Erythema—Betamethasone—ulcerative colitis	0.000964	0.00119	CcSEcCtD
Remifentanil—Erythema—Dexamethasone—ulcerative colitis	0.000964	0.00119	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000962	0.0054	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.000961	0.0054	CbGpPWpGaD
Remifentanil—Hallucination—Prednisone—ulcerative colitis	0.000959	0.00119	CcSEcCtD
Remifentanil—Anxiety—Hydrocortisone—ulcerative colitis	0.000957	0.00118	CcSEcCtD
Remifentanil—Hypersensitivity—Mesalazine—ulcerative colitis	0.000954	0.00118	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000954	0.00118	CcSEcCtD
Remifentanil—Syncope—Triamcinolone—ulcerative colitis	0.000953	0.00118	CcSEcCtD
Remifentanil—Syncope—Methylprednisolone—ulcerative colitis	0.00095	0.00117	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000949	0.00533	CbGpPWpGaD
Remifentanil—Nausea—Budesonide—ulcerative colitis	0.000946	0.00117	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000943	0.00116	CcSEcCtD
Remifentanil—Oedema—Prednisolone—ulcerative colitis	0.000943	0.00116	CcSEcCtD
Remifentanil—Dizziness—Azathioprine—ulcerative colitis	0.00094	0.00116	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CCL20—ulcerative colitis	0.000937	0.00526	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000936	0.00526	CbGpPWpGaD
Remifentanil—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000934	0.00115	CcSEcCtD
Remifentanil—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000932	0.00115	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000929	0.00522	CbGpPWpGaD
Remifentanil—Shock—Prednisolone—ulcerative colitis	0.000927	0.00115	CcSEcCtD
Remifentanil—Cough—Triamcinolone—ulcerative colitis	0.000927	0.00115	CcSEcCtD
Remifentanil—Oedema—Hydrocortisone—ulcerative colitis	0.000921	0.00114	CcSEcCtD
Remifentanil—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000921	0.00114	CcSEcCtD
Remifentanil—Convulsion—Triamcinolone—ulcerative colitis	0.00092	0.00114	CcSEcCtD
Remifentanil—Tachycardia—Prednisolone—ulcerative colitis	0.00092	0.00114	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000918	0.00516	CbGpPWpGaD
Remifentanil—Convulsion—Methylprednisolone—ulcerative colitis	0.000918	0.00113	CcSEcCtD
Remifentanil—Hypertension—Triamcinolone—ulcerative colitis	0.000917	0.00113	CcSEcCtD
Remifentanil—Pruritus—Mesalazine—ulcerative colitis	0.000916	0.00113	CcSEcCtD
Remifentanil—Hypertension—Methylprednisolone—ulcerative colitis	0.000915	0.00113	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000912	0.00512	CbGpPWpGaD
Remifentanil—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000911	0.00113	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000908	0.0051	CbGpPWpGaD
Remifentanil—Shock—Hydrocortisone—ulcerative colitis	0.000906	0.00112	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000904	0.00508	CbGpPWpGaD
Remifentanil—Vomiting—Azathioprine—ulcerative colitis	0.000904	0.00112	CcSEcCtD
Remifentanil—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000903	0.00112	CcSEcCtD
Remifentanil—Anxiety—Methylprednisolone—ulcerative colitis	0.000899	0.00111	CcSEcCtD
Remifentanil—Tachycardia—Hydrocortisone—ulcerative colitis	0.000899	0.00111	CcSEcCtD
Remifentanil—Rash—Azathioprine—ulcerative colitis	0.000896	0.00111	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000896	0.00111	CcSEcCtD
Remifentanil—Dermatitis—Azathioprine—ulcerative colitis	0.000895	0.00111	CcSEcCtD
Remifentanil—Flushing—Prednisone—ulcerative colitis	0.000895	0.00111	CcSEcCtD
Remifentanil—Skin disorder—Hydrocortisone—ulcerative colitis	0.000894	0.0011	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000892	0.00501	CbGpPWpGaD
Remifentanil—Headache—Azathioprine—ulcerative colitis	0.00089	0.0011	CcSEcCtD
Remifentanil—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00089	0.0011	CcSEcCtD
Remifentanil—Diarrhoea—Mesalazine—ulcerative colitis	0.000886	0.00109	CcSEcCtD
Remifentanil—Dry mouth—Triamcinolone—ulcerative colitis	0.000884	0.00109	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—ulcerative colitis	0.000875	0.00108	CcSEcCtD
Remifentanil—Confusional state—Methylprednisolone—ulcerative colitis	0.000872	0.00108	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—ulcerative colitis	0.000871	0.00108	CcSEcCtD
Remifentanil—Oedema—Triamcinolone—ulcerative colitis	0.000867	0.00107	CcSEcCtD
Remifentanil—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000867	0.00107	CcSEcCtD
Remifentanil—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000865	0.00107	CcSEcCtD
Remifentanil—Syncope—Dexamethasone—ulcerative colitis	0.000864	0.00107	CcSEcCtD
Remifentanil—Syncope—Betamethasone—ulcerative colitis	0.000864	0.00107	CcSEcCtD
Remifentanil—Arrhythmia—Prednisone—ulcerative colitis	0.000861	0.00106	CcSEcCtD
Remifentanil—Hypotension—Hydrocortisone—ulcerative colitis	0.00086	0.00106	CcSEcCtD
Remifentanil—Dizziness—Mesalazine—ulcerative colitis	0.000856	0.00106	CcSEcCtD
Remifentanil—Shock—Triamcinolone—ulcerative colitis	0.000853	0.00105	CcSEcCtD
Remifentanil—Shock—Methylprednisolone—ulcerative colitis	0.000851	0.00105	CcSEcCtD
Remifentanil—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000848	0.00105	CcSEcCtD
Remifentanil—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000847	0.00105	CcSEcCtD
Remifentanil—Loss of consciousness—Betamethasone—ulcerative colitis	0.000847	0.00105	CcSEcCtD
Remifentanil—Paraesthesia—Prednisolone—ulcerative colitis	0.000846	0.00105	CcSEcCtD
Remifentanil—Tachycardia—Triamcinolone—ulcerative colitis	0.000846	0.00105	CcSEcCtD
Remifentanil—Nausea—Azathioprine—ulcerative colitis	0.000844	0.00104	CcSEcCtD
Remifentanil—Tachycardia—Methylprednisolone—ulcerative colitis	0.000844	0.00104	CcSEcCtD
Remifentanil—Skin disorder—Methylprednisolone—ulcerative colitis	0.00084	0.00104	CcSEcCtD
Remifentanil—Erythema—Prednisone—ulcerative colitis	0.000839	0.00104	CcSEcCtD
Remifentanil—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000838	0.00104	CcSEcCtD
Remifentanil—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000836	0.00103	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000835	0.00469	CbGpPWpGaD
Remifentanil—Convulsion—Betamethasone—ulcerative colitis	0.000835	0.00103	CcSEcCtD
Remifentanil—Convulsion—Dexamethasone—ulcerative colitis	0.000835	0.00103	CcSEcCtD
Remifentanil—Hypertension—Dexamethasone—ulcerative colitis	0.000832	0.00103	CcSEcCtD
Remifentanil—Hypertension—Betamethasone—ulcerative colitis	0.000832	0.00103	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000831	0.00467	CbGpPWpGaD
Remifentanil—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000827	0.00102	CcSEcCtD
Remifentanil—Vomiting—Mesalazine—ulcerative colitis	0.000823	0.00102	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CCL20—ulcerative colitis	0.000822	0.00461	CbGpPWpGaD
Remifentanil—Anxiety—Dexamethasone—ulcerative colitis	0.000818	0.00101	CcSEcCtD
Remifentanil—Anxiety—Betamethasone—ulcerative colitis	0.000818	0.00101	CcSEcCtD
Remifentanil—Rash—Mesalazine—ulcerative colitis	0.000816	0.00101	CcSEcCtD
Remifentanil—Dermatitis—Mesalazine—ulcerative colitis	0.000816	0.00101	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000813	0.00456	CbGpPWpGaD
Remifentanil—Headache—Mesalazine—ulcerative colitis	0.000811	0.001	CcSEcCtD
Remifentanil—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00081	0.001	CcSEcCtD
Remifentanil—Hypotension—Methylprednisolone—ulcerative colitis	0.000808	0.000999	CcSEcCtD
Remifentanil—Pain—Prednisolone—ulcerative colitis	0.000806	0.000996	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000803	0.00451	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000796	0.00447	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000795	0.000982	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000791	0.00444	CbGpPWpGaD
Remifentanil—Pain—Hydrocortisone—ulcerative colitis	0.000787	0.000973	CcSEcCtD
Remifentanil—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000787	0.000972	CcSEcCtD
Remifentanil—Oedema—Betamethasone—ulcerative colitis	0.000787	0.000972	CcSEcCtD
Remifentanil—Oedema—Dexamethasone—ulcerative colitis	0.000787	0.000972	CcSEcCtD
Remifentanil—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000787	0.000972	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000785	0.00441	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCR6—ulcerative colitis	0.000785	0.00441	CbGpPWpGaD
Remifentanil—Paraesthesia—Triamcinolone—ulcerative colitis	0.000778	0.000962	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisolone—ulcerative colitis	0.000777	0.00096	CcSEcCtD
Remifentanil—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000777	0.00096	CcSEcCtD
Remifentanil—Anaemia—Prednisone—ulcerative colitis	0.000776	0.000958	CcSEcCtD
Remifentanil—Shock—Betamethasone—ulcerative colitis	0.000774	0.000956	CcSEcCtD
Remifentanil—Shock—Dexamethasone—ulcerative colitis	0.000774	0.000956	CcSEcCtD
Remifentanil—Dyspnoea—Triamcinolone—ulcerative colitis	0.000773	0.000955	CcSEcCtD
Remifentanil—Nervous system disorder—Betamethasone—ulcerative colitis	0.000771	0.000953	CcSEcCtD
Remifentanil—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000771	0.000953	CcSEcCtD
Remifentanil—Agitation—Prednisone—ulcerative colitis	0.000771	0.000953	CcSEcCtD
Remifentanil—Thrombocytopenia—Betamethasone—ulcerative colitis	0.00077	0.000952	CcSEcCtD
Remifentanil—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.00077	0.000952	CcSEcCtD
Remifentanil—Nausea—Mesalazine—ulcerative colitis	0.000769	0.00095	CcSEcCtD
Remifentanil—Tachycardia—Betamethasone—ulcerative colitis	0.000768	0.000949	CcSEcCtD
Remifentanil—Tachycardia—Dexamethasone—ulcerative colitis	0.000768	0.000949	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000764	0.00429	CbGpPWpGaD
Remifentanil—Dyspepsia—Triamcinolone—ulcerative colitis	0.000763	0.000943	CcSEcCtD
Remifentanil—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000761	0.000941	CcSEcCtD
Remifentanil—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.00076	0.00094	CcSEcCtD
Remifentanil—Hyperhidrosis—Betamethasone—ulcerative colitis	0.00076	0.00094	CcSEcCtD
Remifentanil—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000759	0.000937	CcSEcCtD
Remifentanil—Syncope—Prednisone—ulcerative colitis	0.000753	0.00093	CcSEcCtD
Remifentanil—Urticaria—Prednisolone—ulcerative colitis	0.000749	0.000925	CcSEcCtD
Remifentanil—Pain—Triamcinolone—ulcerative colitis	0.000741	0.000916	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—ulcerative colitis	0.000738	0.000911	CcSEcCtD
Remifentanil—Hypotension—Dexamethasone—ulcerative colitis	0.000735	0.000908	CcSEcCtD
Remifentanil—Hypotension—Betamethasone—ulcerative colitis	0.000735	0.000908	CcSEcCtD
Remifentanil—OPRD1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000735	0.00412	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000732	0.00411	CbGpPWpGaD
Remifentanil—Urticaria—Hydrocortisone—ulcerative colitis	0.000731	0.000904	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000729	0.00409	CbGpPWpGaD
Remifentanil—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000728	0.000899	CcSEcCtD
Remifentanil—Convulsion—Prednisone—ulcerative colitis	0.000727	0.000899	CcSEcCtD
Remifentanil—Hypertension—Prednisone—ulcerative colitis	0.000725	0.000895	CcSEcCtD
Remifentanil—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000714	0.000883	CcSEcCtD
Remifentanil—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000713	0.000881	CcSEcCtD
Remifentanil—Anxiety—Prednisone—ulcerative colitis	0.000712	0.00088	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00071	0.000877	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—RELA—ulcerative colitis	0.000708	0.00398	CbGpPWpGaD
Remifentanil—Paraesthesia—Dexamethasone—ulcerative colitis	0.000706	0.000873	CcSEcCtD
Remifentanil—Paraesthesia—Betamethasone—ulcerative colitis	0.000706	0.000873	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000704	0.00395	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL20—ulcerative colitis	0.000695	0.0039	CbGpPWpGaD
Remifentanil—Hypersensitivity—Prednisolone—ulcerative colitis	0.000695	0.000858	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—CD4—ulcerative colitis	0.000693	0.00389	CbGpPWpGaD
Remifentanil—Dyspepsia—Betamethasone—ulcerative colitis	0.000692	0.000855	CcSEcCtD
Remifentanil—Dyspepsia—Dexamethasone—ulcerative colitis	0.000692	0.000855	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000691	0.00388	CbGpPWpGaD
Remifentanil—Urticaria—Triamcinolone—ulcerative colitis	0.000689	0.000851	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CCR6—ulcerative colitis	0.000689	0.00387	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000688	0.00386	CbGpPWpGaD
Remifentanil—Urticaria—Methylprednisolone—ulcerative colitis	0.000687	0.000849	CcSEcCtD
Remifentanil—Body temperature increased—Triamcinolone—ulcerative colitis	0.000685	0.000847	CcSEcCtD
Remifentanil—Oedema—Prednisone—ulcerative colitis	0.000685	0.000846	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—ulcerative colitis	0.000685	0.000846	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000679	0.000839	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000679	0.000839	CcSEcCtD
Remifentanil—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000678	0.000838	CcSEcCtD
Remifentanil—Shock—Prednisone—ulcerative colitis	0.000674	0.000833	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000673	0.00378	CbGpPWpGaD
Remifentanil—Pain—Dexamethasone—ulcerative colitis	0.000673	0.000831	CcSEcCtD
Remifentanil—Pain—Betamethasone—ulcerative colitis	0.000673	0.000831	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—ulcerative colitis	0.000672	0.00083	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—ulcerative colitis	0.000669	0.000826	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—ulcerative colitis	0.000665	0.000822	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—ulcerative colitis	0.000662	0.000818	CcSEcCtD
Remifentanil—Pruritus—Hydrocortisone—ulcerative colitis	0.000651	0.000805	CcSEcCtD
Remifentanil—Feeling abnormal—Betamethasone—ulcerative colitis	0.000648	0.000801	CcSEcCtD
Remifentanil—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000648	0.000801	CcSEcCtD
Remifentanil—OPRK1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000644	0.00362	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL1B—ulcerative colitis	0.00064	0.0036	CbGpPWpGaD
Remifentanil—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000639	0.000789	CcSEcCtD
Remifentanil—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000637	0.000787	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—GHRL—ulcerative colitis	0.000633	0.00355	CbGpPWpGaD
Remifentanil—Diarrhoea—Hydrocortisone—ulcerative colitis	0.00063	0.000778	CcSEcCtD
Remifentanil—Urticaria—Dexamethasone—ulcerative colitis	0.000625	0.000772	CcSEcCtD
Remifentanil—Urticaria—Betamethasone—ulcerative colitis	0.000625	0.000772	CcSEcCtD
Remifentanil—Dizziness—Prednisolone—ulcerative colitis	0.000623	0.00077	CcSEcCtD
Remifentanil—Body temperature increased—Betamethasone—ulcerative colitis	0.000622	0.000768	CcSEcCtD
Remifentanil—Body temperature increased—Dexamethasone—ulcerative colitis	0.000622	0.000768	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000619	0.00348	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000616	0.00346	CbGpPWpGaD
Remifentanil—Paraesthesia—Prednisone—ulcerative colitis	0.000615	0.00076	CcSEcCtD
Remifentanil—Pruritus—Triamcinolone—ulcerative colitis	0.000613	0.000758	CcSEcCtD
Remifentanil—Pruritus—Methylprednisolone—ulcerative colitis	0.000612	0.000756	CcSEcCtD
Remifentanil—Dizziness—Hydrocortisone—ulcerative colitis	0.000609	0.000752	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000606	0.0034	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000603	0.00339	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000603	0.00339	CbGpPWpGaD
Remifentanil—Dyspepsia—Prednisone—ulcerative colitis	0.000603	0.000745	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—NFKB1—ulcerative colitis	0.000597	0.00335	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000595	0.00334	CbGpPWpGaD
Remifentanil—Rash—Prednisolone—ulcerative colitis	0.000594	0.000734	CcSEcCtD
Remifentanil—Dermatitis—Prednisolone—ulcerative colitis	0.000594	0.000734	CcSEcCtD
Remifentanil—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000592	0.000731	CcSEcCtD
Remifentanil—Headache—Prednisolone—ulcerative colitis	0.000591	0.00073	CcSEcCtD
Remifentanil—Constipation—Prednisone—ulcerative colitis	0.000586	0.000724	CcSEcCtD
Remifentanil—Vomiting—Hydrocortisone—ulcerative colitis	0.000585	0.000723	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CCR6—ulcerative colitis	0.000582	0.00327	CbGpPWpGaD
Remifentanil—Rash—Hydrocortisone—ulcerative colitis	0.00058	0.000717	CcSEcCtD
Remifentanil—Dermatitis—Hydrocortisone—ulcerative colitis	0.00058	0.000717	CcSEcCtD
Remifentanil—Headache—Hydrocortisone—ulcerative colitis	0.000577	0.000713	CcSEcCtD
Remifentanil—Dizziness—Triamcinolone—ulcerative colitis	0.000573	0.000708	CcSEcCtD
Remifentanil—Dizziness—Methylprednisolone—ulcerative colitis	0.000572	0.000707	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisone—ulcerative colitis	0.000564	0.000697	CcSEcCtD
Remifentanil—Nausea—Prednisolone—ulcerative colitis	0.00056	0.000692	CcSEcCtD
Remifentanil—Pruritus—Dexamethasone—ulcerative colitis	0.000557	0.000688	CcSEcCtD
Remifentanil—Pruritus—Betamethasone—ulcerative colitis	0.000557	0.000688	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—GHRL—ulcerative colitis	0.000555	0.00312	CbGpPWpGaD
Remifentanil—Vomiting—Triamcinolone—ulcerative colitis	0.000551	0.000681	CcSEcCtD
Remifentanil—Vomiting—Methylprednisolone—ulcerative colitis	0.00055	0.000679	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000548	0.00308	CbGpPWpGaD
Remifentanil—Nausea—Hydrocortisone—ulcerative colitis	0.000547	0.000676	CcSEcCtD
Remifentanil—Rash—Triamcinolone—ulcerative colitis	0.000547	0.000675	CcSEcCtD
Remifentanil—Dermatitis—Triamcinolone—ulcerative colitis	0.000546	0.000675	CcSEcCtD
Remifentanil—Rash—Methylprednisolone—ulcerative colitis	0.000545	0.000674	CcSEcCtD
Remifentanil—Dermatitis—Methylprednisolone—ulcerative colitis	0.000545	0.000673	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000544	0.00306	CbGpPWpGaD
Remifentanil—Urticaria—Prednisone—ulcerative colitis	0.000544	0.000672	CcSEcCtD
Remifentanil—Headache—Triamcinolone—ulcerative colitis	0.000543	0.000671	CcSEcCtD
Remifentanil—Headache—Methylprednisolone—ulcerative colitis	0.000542	0.000669	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—ulcerative colitis	0.000542	0.000669	CcSEcCtD
Remifentanil—Diarrhoea—Betamethasone—ulcerative colitis	0.000538	0.000665	CcSEcCtD
Remifentanil—Diarrhoea—Dexamethasone—ulcerative colitis	0.000538	0.000665	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CCL20—ulcerative colitis	0.00053	0.00297	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000529	0.00297	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000524	0.00294	CbGpPWpGaD
Remifentanil—Dizziness—Betamethasone—ulcerative colitis	0.00052	0.000643	CcSEcCtD
Remifentanil—Dizziness—Dexamethasone—ulcerative colitis	0.00052	0.000643	CcSEcCtD
Remifentanil—Nausea—Triamcinolone—ulcerative colitis	0.000515	0.000636	CcSEcCtD
Remifentanil—Nausea—Methylprednisolone—ulcerative colitis	0.000514	0.000635	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000512	0.00288	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00051	0.00286	CbGpPWpGaD
Remifentanil—Hypersensitivity—Prednisone—ulcerative colitis	0.000505	0.000624	CcSEcCtD
Remifentanil—Vomiting—Betamethasone—ulcerative colitis	0.0005	0.000618	CcSEcCtD
Remifentanil—Vomiting—Dexamethasone—ulcerative colitis	0.0005	0.000618	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000498	0.0028	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—TGFB1—ulcerative colitis	0.000498	0.00279	CbGpPWpGaD
Remifentanil—Rash—Dexamethasone—ulcerative colitis	0.000496	0.000613	CcSEcCtD
Remifentanil—Rash—Betamethasone—ulcerative colitis	0.000496	0.000613	CcSEcCtD
Remifentanil—Dermatitis—Dexamethasone—ulcerative colitis	0.000495	0.000612	CcSEcCtD
Remifentanil—Dermatitis—Betamethasone—ulcerative colitis	0.000495	0.000612	CcSEcCtD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000495	0.00278	CbGpPWpGaD
Remifentanil—Headache—Betamethasone—ulcerative colitis	0.000493	0.000609	CcSEcCtD
Remifentanil—Headache—Dexamethasone—ulcerative colitis	0.000493	0.000609	CcSEcCtD
Remifentanil—Pruritus—Prednisone—ulcerative colitis	0.000485	0.000599	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CCL20—ulcerative colitis	0.000481	0.0027	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00048	0.0027	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000472	0.00265	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—GHRL—ulcerative colitis	0.000469	0.00263	CbGpPWpGaD
Remifentanil—Diarrhoea—Prednisone—ulcerative colitis	0.000469	0.000579	CcSEcCtD
Remifentanil—Nausea—Betamethasone—ulcerative colitis	0.000467	0.000577	CcSEcCtD
Remifentanil—Nausea—Dexamethasone—ulcerative colitis	0.000467	0.000577	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000464	0.00261	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000459	0.00258	CbGpPWpGaD
Remifentanil—Dizziness—Prednisone—ulcerative colitis	0.000453	0.00056	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—GNA12—ulcerative colitis	0.000452	0.00254	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000447	0.00251	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000444	0.00249	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000437	0.00245	CbGpPWpGaD
Remifentanil—Vomiting—Prednisone—ulcerative colitis	0.000436	0.000538	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000434	0.00244	CbGpPWpGaD
Remifentanil—Rash—Prednisone—ulcerative colitis	0.000432	0.000534	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—ulcerative colitis	0.000432	0.000533	CcSEcCtD
Remifentanil—Headache—Prednisone—ulcerative colitis	0.000429	0.00053	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000429	0.00241	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL20—ulcerative colitis	0.000422	0.00237	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000418	0.00235	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000414	0.00232	CbGpPWpGaD
Remifentanil—Nausea—Prednisone—ulcerative colitis	0.000407	0.000503	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000406	0.00228	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR6—ulcerative colitis	0.000403	0.00226	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GNA12—ulcerative colitis	0.000397	0.00223	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SEL1L—ulcerative colitis	0.000393	0.00221	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000392	0.0022	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000391	0.00219	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000389	0.00219	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000388	0.00218	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000376	0.00211	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL6—ulcerative colitis	0.000375	0.00211	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000369	0.00207	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000367	0.00206	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000367	0.00206	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000358	0.00201	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL20—ulcerative colitis	0.000356	0.002	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000355	0.00199	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR6—ulcerative colitis	0.000353	0.00198	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00035	0.00196	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SEL1L—ulcerative colitis	0.000345	0.00193	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000343	0.00192	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GNA12—ulcerative colitis	0.000335	0.00188	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000332	0.00187	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000329	0.00185	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GHRL—ulcerative colitis	0.000325	0.00182	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCR1—ulcerative colitis	0.000324	0.00182	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000318	0.00178	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CALM3—ulcerative colitis	0.000315	0.00177	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000314	0.00176	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000311	0.00175	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00031	0.00174	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR6—ulcerative colitis	0.000299	0.00168	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000296	0.00166	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000291	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SEL1L—ulcerative colitis	0.000291	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00029	0.00163	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GHRL—ulcerative colitis	0.000285	0.0016	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL20—ulcerative colitis	0.000284	0.0016	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCR1—ulcerative colitis	0.000284	0.00159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CALM3—ulcerative colitis	0.000276	0.00155	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000269	0.00151	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GNA12—ulcerative colitis	0.000267	0.0015	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000265	0.00149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000263	0.00148	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00026	0.00146	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCR2—ulcerative colitis	0.000253	0.00142	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000253	0.00142	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000251	0.00141	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL20—ulcerative colitis	0.000249	0.0014	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000246	0.00138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GHRL—ulcerative colitis	0.000241	0.00135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR1—ulcerative colitis	0.00024	0.00135	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR6—ulcerative colitis	0.000238	0.00134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000236	0.00132	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	0.000234	0.00132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	0.000233	0.00131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000228	0.00128	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	0.000226	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	0.000222	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000222	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00022	0.00124	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000219	0.00123	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	0.000211	0.00118	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	0.00021	0.00118	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	0.000209	0.00117	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	0.0002	0.00112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000199	0.00112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	0.000198	0.00111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	0.000198	0.00111	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	0.000192	0.00108	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	0.000188	0.00105	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000188	0.00105	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000186	0.00105	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	0.000186	0.00104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	0.000184	0.00103	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	0.000183	0.00103	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	0.000176	0.000991	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000169	0.00095	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	0.000168	0.000945	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	0.000167	0.000939	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	0.000163	0.000915	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	0.000161	0.000901	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	0.000159	0.000892	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000157	0.00088	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	0.000155	0.000872	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000143	0.000803	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	0.000142	0.000799	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	0.000142	0.000799	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	0.000139	0.000782	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	0.000138	0.000773	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000137	0.000772	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	0.000137	0.000767	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	0.000136	0.000762	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	0.000135	0.000757	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	0.00013	0.000729	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000125	0.000704	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	0.000125	0.000701	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	0.000124	0.000697	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	0.00012	0.000673	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	0.000118	0.000664	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	0.000118	0.000661	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000116	0.000652	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000114	0.000639	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	0.000109	0.000611	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000106	0.000595	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	0.000105	0.000592	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	0.000101	0.000569	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	9.99e-05	0.000561	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	9.63e-05	0.00054	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	9.2e-05	0.000516	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	8.41e-05	0.000472	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RELA—ulcerative colitis	8.14e-05	0.000457	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	7.67e-05	0.000431	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	7.37e-05	0.000414	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—ulcerative colitis	7.33e-05	0.000412	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	7.3e-05	0.00041	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RELA—ulcerative colitis	7.14e-05	0.000401	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	6.94e-05	0.00039	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	6.87e-05	0.000386	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	6.73e-05	0.000378	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—ulcerative colitis	6.43e-05	0.000361	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	6.4e-05	0.000359	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	6.23e-05	0.00035	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	6.17e-05	0.000346	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	6.09e-05	0.000342	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RELA—ulcerative colitis	6.03e-05	0.000339	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	6.02e-05	0.000338	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	5.72e-05	0.000321	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	5.69e-05	0.000319	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—ulcerative colitis	5.43e-05	0.000305	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	5.41e-05	0.000304	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	5.41e-05	0.000304	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	5.14e-05	0.000289	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	5.09e-05	0.000286	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	5.02e-05	0.000282	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—ulcerative colitis	4.71e-05	0.000264	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	4.57e-05	0.000257	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—ulcerative colitis	4.31e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	4.24e-05	0.000238	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—ulcerative colitis	4.13e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—ulcerative colitis	3.78e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—ulcerative colitis	3.49e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—ulcerative colitis	3.19e-05	0.000179	CbGpPWpGaD
